Beaird Harris Wealth Management, LLC
Position in REPL — Replimune Group, Inc.
CIK 1908938
DALLAS, TX
Position in REPL
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$7,527
New position
Shares Held
680
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#167
of 198 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Beaird Harris Wealth Management, LLC holds $41,457 across 13 Biotechnology names. REPL ranks #3 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
33 | $16,392 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
41 | $7,678 | |
| 3 | REPL |
Replimune Group, Inc.
This page
|
680 | $7,527 | |
| 4 | MDXG |
Mimedx Group, Inc.
|
1,270 | $4,889 | |
| 5 | ARGX |
Argenx SE
|
2 | $1,855 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4 | $1,204 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1 | $623 | |
| 8 | INCY |
Incyte Corp
|
5 | $566 |
All Filings in REPL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,527 | 680 | Shares | Sole | 2026-07-08 | |
| No filing history on record for this holder in this stock. | ||||||